Comparison between Dr.Lal PathLabs IPO and Quick Heal Technologies IPO.
Dr.Lal PathLabs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Quick Heal Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Dr.Lal PathLabs IPO is up to ₹631.91 Cr whereas the issue size of the Quick Heal Technologies IPO is up to ₹451.25 Cr. The final issue price of Dr.Lal PathLabs IPO is ₹550.00 per share and of Quick Heal Technologies IPO is ₹321.00 per share.
| Dr.Lal PathLabs IPO | Quick Heal Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹311.00 per share |
| Issue Price (Upper) | ₹550.00 per share | ₹321.00 per share |
| Issue Price (Final) | ₹550.00 per share | ₹321.00 per share |
| Discount (Retail) | ₹15.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 20 shares | 45 shares |
| Fresh Issue Size | 0 shares | 77,88,161 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹250.00 Cr |
| OFS Issue Size | 1,16,00,000 shares | 62,69,558 shares |
| OFS Issue Size (Amount) | up to ₹631.91 Cr | up to ₹201.25 Cr |
| Issue Size Total | 1,16,00,000 shares | 1,40,57,719 shares |
| Issue Size Total (Amount) | up to ₹631.91 Cr | up to ₹451.25 Cr |
Dr.Lal PathLabs IPO opens on Dec 08, 2015, while Quick Heal Technologies IPO opens on Feb 08, 2016. The closing date of Dr.Lal PathLabs IPO and Quick Heal Technologies IPO is Dec 10, 2015, and Feb 10, 2016, respectively.
| Dr.Lal PathLabs IPO | Quick Heal Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Dec 07, 2015 | Feb 05, 2016 |
| Issue Open | Dec 08, 2015 | Feb 08, 2016 |
| Issue Close | Dec 10, 2015 | Feb 10, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 23, 2015 | Feb 18, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dr.Lal PathLabs IPO P/E ratio is , as compared to Quick Heal Technologies IPO P/E ratio of .
| Dr.Lal PathLabs IPO | Quick Heal Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.67 | |||||
| Promoter Shareholding (Post-Issue) | 58.7 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹4545.46 Cr. | ₹2247.96 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 27.85 |
In the Dr.Lal PathLabs IPO Retail Individual Investors (RII) are offered 40,60,000 shares while in Quick Heal Technologies IPO retail investors are offered 40,60,000 shares. Qualified Institutional Buyers (QIB) are offered 23,20,000 shares in Dr.Lal PathLabs IPO and 27,80,391 shares in Quick Heal Technologies IPO.
| Dr.Lal PathLabs IPO | Quick Heal Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 34,80,000 shares | 41,70,586 shares |
| Market Maker Reservation | ||
| QIB | 23,20,000 shares | 27,80,391 shares |
| NII | 17,40,000 shares | 20,85,294 shares |
| RII | 40,60,000 shares | 48,65,685 shares |
| Employee | 1,55,763 shares | |
| Others | ||
| Total | 1,16,00,000 shares | 1,40,57,719 shares |
Dr.Lal PathLabs IPO subscribed 33.41x in total, whereas Quick Heal Technologies IPO subscribed 10.79x.
| Dr.Lal PathLabs IPO | Quick Heal Technologies IPO | |
|---|---|---|
| QIB (times) | 63.56x | 4.34x |
| NII (times) | 61.28x | 36.69x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.24x | 3.82x |
| Employee (times) | 0.23x | |
| Other (times) | ||
| Total (times) | 33.41x | 10.79x |
